Flow Pharma's Unattributed Round

Flow Pharma raised a round of funding on April 30, 2011.

Flow Pharma is developing FlowVax HPV to treat cervical cancer, using computational modeling and AI deep learning to design synthetic, CTL Immuno-Oncology therapeutics.…

Articles about Flow Pharma's Unattributed Round: